Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7633166 | Journal of Pharmaceutical and Biomedical Analysis | 2012 | 11 Pages |
Abstract
In this work, metabolites of cyadox (CYX) produced by liver microsomes, primary hepatocytes and intestinal microflora systems of rat, chicken and swine were identified and elucidated using ultra-performance liquid chromatography/quadrupole time-of-flight tandem mass spectrometry (UPLC/Q-TOF-MS). Expected and unexpected metabolites were found out using MetabolynxXS software by automatically comparing MSE data from the sample and control. The metabolites were reliably characterized by accurate MS/MS spectra and their different fragmentation pathways. In total twenty-four metabolites were identified in the three in vitro systems, fifteen of which were novel. The results revealed the main metabolic pathways of CYX were NâO group reduction, hydroxylation and hydrolysis reactions. Besides, methylation and acetylation reactions which represented phase II drug biotransformations were recognized in the in vitro systems of chicken firstly. It also showed that the metabolic capacity and rapidity of chicken and swine was greater than rat, with some differences in metabolic fate and metabolite varieties. This work contributes to the comprehensive understanding of in vitro metabolism of CYX, and will provide an important basis for further in vivo metabolism study and toxicological safety evaluation.
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Haixia Wu, Linxia Li, Jianzhong Shen, Ying Wang, Kaili Liu, Suxia Zhang,